OptimizeRx Corporation

Digital-health engagement platform (NASDAQ: OPRX).

📍 Waltham, Massachusetts, USA

OptimizeRx Corporation is a digital healthcare technology company providing dynamic, omnichannel solutions designed to foster care-focused engagement across the life sciences sector, connecting life science brands with healthcare providers (HCPs) and patients. Operating in the United States, the company utilizes best-in-class technology, including the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT), which are AI-driven tools that deliver hyper-local and relevant engagement. OptimizeRx aims to help patients better afford and adhere to their treatment regimens, connecting over two million HCPs. The company's leadership and governance are highlighted by the appointment of Mary Varghese Presti, the Microsoft Health & Life Sciences COO, to the board of directors. For financial and corporate governance matters, Edward Stelmakh serves as the Chief Financial & Strategic Officer, and Andy D'Silva manages Investor Relations. The company has recently navigated market challenges, lowering its 2026 revenue forecast due to shifting pharma spend, prompting a downgrade to 'Sell' amid headwinds. Furthermore, OptimizeRx has established strategic partnerships, such as with Lamar Advertising, to reach clinically relevant patient populations.